Anaphylaxis to Patent Blue V. II. A unique IgE-mediated reaction

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 1, 2010, Pages 124-129

  Johansson, S G O ^a,b   Nopp, A ^a   Oman H ^c   Stahl Skov, P ^d   Hunting, A S ^e   Guttormsen, A B ^f,g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c MIAB   (Sweden)

^d Mental Health Services CPH   (Denmark)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF BERGEN   (Norway)

Author keywords

Basophils; CD sens; Histamine release

Indexed keywords

DISULFINE BLUE; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY; PHOSPHATE BUFFERED SALINE;

ANAPHYLAXIS; ARTICLE; BASOPHIL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ELUTION; HEATING; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOLOGICAL TECHNIQUE; PH; PRIORITY JOURNAL; PROVOCATION TEST; ROOM TEMPERATURE;

ANAPHYLAXIS; BASOPHILS; COLORING AGENTS; HUMANS; IMMUNOGLOBULIN E; ROSANILINE DYES;

EID: 72049105589     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02191.x     Document Type: Article

References (19)

1. Laxenaire MC. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993;12:91-96.
2. Harboe T, Guttormsen AB, Irgens A, Dybendal T, Florvaag E. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005;102:897-903.
3. Cheung J, O'Leary JJ. Allergic reaction to chlorhexidine in an anaesthetised patient. Anaesth Intensive Care 1985;13:429-430.
4. Garvey LH, Roed-Petersen J, Husum B. Anaphylactic reactions in anaesthetised patients - four cases of chlorhexidine allergy. Acta Anaesthesiol Scand 2001;45:1290-1294.
5. Bousquet J, Flahault A, Vandenplas O, Ameille J, Duron JJ, Pecquet C et al. Natural rubber latex allergy among health care workers: a systematic review of the evidence. J Allergy Clin Immunol 2006;118:447-454.
6. Florvaag E, Johansson SG, Oman H, Venemalm L, Degerbeck F, Dybendal T et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005;49: 437-444.
7. Hunting AS, Nopp A, Johansson SGO, Wilhelmsen V, Anderssen F, Guttormsen AB. Anaphylaxis to Patent Blue V. I. Clinical aspects. Allergy 2009;[E-pub ahead of print, DOI:10.1111/j.1398-9995.2009.02192.x].
8. Johansson SGO, Nopp A, van Hage M, Olofsson N, Lundahl J, Wehlin L et al. Passive IgE-sensitization by blood transfusion. Allergy 2005;60:1192-1199.
9. Garvey LH, Kroigaard M, Poulsen LK, Skov PS, Mosbech H, Vennemalm L et al. IgE mediated allergy to chlorhexidine. J Allergy clin Immunol 2007;120:409-415.
10. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anaesthesia. Anesthesiology 2000;93:1145-1146.
11. Ebo DG, Wets RD, Spiessens TK, Bridts CH, Stevens WJ. Flow-assisted diagnosis of anaphylaxis to patent blue. Allergy 2005;60:703-704.
12. Dewachter P, Mouton-Faivre C, Benhaijoub A, Abel-Decollogne F, Mertes PM. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Acta Anaesthesiol Scand 2006;50:245-247.
13. Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006;96:497-500.
14. Guttormsen AB. Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand. 2001;45:1189-1190.
15. Nopp A, Johansson SGO, Ankerst J, Bylin G, Cardell LO, Grönneberg R et al. Basophil allergen threshold sensitivity. A useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006;61:298-302.
16. Nopp A, Cardell LO, Johansson SGO, Öman H. CD-sens: a biological measure of immunological changes stimulated by ASIT. Allergy 2009;64:811-814.
17. MacDonald SM, Lichtenstein LM, Proud D, Plaut M, Naclerio RM, MacGlashan DW, Kagey-Sobotka A. Studies of IgEdependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987;139:506-512.
18. Johansson SGO, Nopp A, Öman H, Ankerst J, Cardell LO, Grönneberg R et al. The size of the disease relevant IgE antibody fraction in relation to "total-IgE" predicts the efficacy of anti-IgE (Xolair®) treatment. Allergy 2009; in press.
19. Zetterström O, Johansson SGO. IgE concentrations measured by PRIST in serum of healthy adults and in patients with respiratory allergy. Allergy 1981;36:537-547.